Beijing, China

Panpan Yu

This inventor holds 1 USPTO granted patent. Top assignee: Beihang University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Panpan Yu. Retrieved from https://idiyas.com/inventor/panpan-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Panpan Yu: Innovator in Biomedical Research

Introduction

Panpan Yu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of biomedicine, particularly in the treatment of ischemic injuries. Her innovative research focuses on the use of fructose in developing drugs aimed at treating cerebral ischemic strokes.

Latest Patents

Panpan Yu holds a patent for the "Use of fructose in preparing drug for treating ischemic injury." This patent outlines a method for utilizing fructose to regulate energy metabolism and redox metabolism in neurons. The research demonstrates that fructose treatment can reduce neuronal mortality following ischemic injury, decrease the area of cerebral infarction in affected animals, and improve neurobehavioral characteristics.

Career Highlights

Panpan Yu is affiliated with Beihang University, where she conducts her research and contributes to advancements in biomedical science. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from ischemic strokes.

Collaborations

Panpan Yu collaborates with esteemed colleagues, including Bing Zhou and Xunming Ji, to further her research initiatives and enhance the impact of her findings in the scientific community.

Conclusion

Panpan Yu's innovative work in the use of fructose for treating ischemic injuries showcases her dedication to advancing biomedical research. Her contributions have the potential to significantly improve therapeutic strategies for cerebral ischemic strokes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…